Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1997 3
1998 7
1999 5
2000 12
2001 7
2002 16
2003 21
2004 10
2005 12
2006 27
2007 38
2008 40
2009 47
2010 45
2011 46
2012 58
2013 45
2014 60
2015 80
2016 59
2017 66
2018 99
2019 79
2020 78
2021 102
2022 52
Text availability
Article attribute
Article type
Publication date

Search Results

875 results
Results by year
Filters applied: . Clear all
Page 1
Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
Lestingi JFP, Trinh QD, Coelho RF, Pontes J Jr, Bastos DA, Nahas WC. Lestingi JFP, et al. Eur Urol. 2021 Jun;79(6):e184-e185. doi: 10.1016/j.eururo.2021.02.038. Epub 2021 Mar 6. Eur Urol. 2021. PMID: 33685836 No abstract available.
Reply to Michael Froehner, Rainer Koch, and Markus Graefen's Letter to the Editor re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62. Comorbidity Measurement in Patients with Prostate Cancer.
van den Bergh RCN, O'Hanlon S, Cornford P, Mottet N; EAU-EANM-ESTRO-ESUR-SIOG Guideline Panel on Prostate Cancer. van den Bergh RCN, et al. Eur Urol. 2021 May;79(5):e139-e140. doi: 10.1016/j.eururo.2021.02.006. Epub 2021 Feb 16. Eur Urol. 2021. PMID: 33608157 No abstract available.
Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, Joāo A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35. Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer Patients.
Patel V. Patel V. Eur Urol. 2021 Feb;79(2):e50-e51. doi: 10.1016/j.eururo.2020.08.041. Epub 2020 Dec 15. Eur Urol. 2021. PMID: 33334623 No abstract available.
Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Würnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, João A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release of the Neurovascular Bundle with Preservation of Dorsal Venous Complex During Robot-assisted Radical Prostatectomy: Optimizing Functional Outcomes. Eur Urol 2020;77:628-35. Incredible Results for Robot-assisted Nerve-sparing Radical Prostatectomy in Prostate Cancer Patients: Rio de Janeiro is Still Beautiful.
Ferreira Coelho R, Afonso de Carvalho P, Betoni Guglielmetti G, Dener Cordeiro M, Carlos Nahas W. Ferreira Coelho R, et al. Eur Urol. 2021 Feb;79(2):e47-e49. doi: 10.1016/j.eururo.2020.08.038. Epub 2020 Nov 5. Eur Urol. 2021. PMID: 33162248 No abstract available.
Reply by Authors.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Briganti A, Tilki D, Graefen M, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. J Urol. 2021 Jul;206(1):79. doi: 10.1097/JU.0000000000001695.03. Epub 2021 Apr 6. J Urol. 2021. PMID: 33820427 No abstract available.
AUTHOR REPLY.
Knipper S, Graefen M, Karakiewicz PI. Knipper S, et al. Urology. 2019 Nov;133:142-143. doi: 10.1016/j.urology.2019.05.055. Urology. 2019. PMID: 31706414 No abstract available.
Eine randomisierte, offene, Multizenterstudie zum Einsatz von Cabazitaxel versus einem Androgenrezeptor (AR)-gerichteten Präparat (Abirateron oder Enzalutamid) bei Patienten mit mCRPC nach Vorbehandlung mit Docetaxel und frühem Nicht-Ansprechen nach AR-gerichtetem Präparat (CARD) – Studie AP 97/17 der AUO.
Rexer H, Graefen M, Wülfing C. Rexer H, et al. Aktuelle Urol. 2018 Jun;49(3):222-224. doi: 10.1055/a-0596-4618. Epub 2018 May 22. Aktuelle Urol. 2018. PMID: 29788522 German. No abstract available.
Reply by Authors.
Fossati N, Scarcella S, Gandaglia G, Suardi N, Robesti D, Boeri L, Karnes RJ, Heidenreich A, Pfister D, Kretschmer A, Buchner A, Stief C, Battaglia A, Joniau S, Van Poppel H, Osmonov D, Juenemann KP, Shariat S, Hiester A, Nini A, Albers P, Tilki D, Graefen M, Gill IS, Mottrie A, Galosi AB, Montorsi F, Briganti A. Fossati N, et al. J Urol. 2020 Aug;204(2):302. doi: 10.1097/JU.0000000000000800.03. Epub 2020 May 19. J Urol. 2020. PMID: 32427046 No abstract available.
875 results